UOC
MYOK

UBS O'Connor’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

UBS O'Connor’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-48,019
Closed -$2.5M – 313
2019
Q1 		$2.5M Buy
+48,019
New +$2.21M 0.07% 145

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

UBS O'Connor's MYOK Position: Q2 2019 in Review

UBS O'Connor sold out of MyoKardia, Inc. Common Stock (MYOK) in Q2 2019, closing a stake of 48,019 shares — an estimated $2.5M sold.

UBS O'Connor first reported a position in MYOK in Q1 2019 and held it in 1 quarter. The position peaked at $2.5M in Q1 2019. 155 funds tracked by Wall St. Rank hold MYOK as of Q2 2019.

  • UBS O'Connor reported no remaining MyoKardia, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • UBS O'Connor sold 48,019 MyoKardia, Inc. Common Stock shares in Q2 2019, an estimated $2.5M.
  • UBS O'Connor first reported a position in MyoKardia, Inc. Common Stock in Q1 2019 and held it in 1 quarter.
  • UBS O'Connor's MyoKardia, Inc. Common Stock position peaked at $2.5M in Q1 2019.
  • 155 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q2 2019.

Based on UBS O'Connor's 13F filing for Q2 2019, filed 14 Aug 2019.